Try our Advanced Search for more refined results

Blue Cross and Blue Shield Association v. Jazz Pharmaceuticals, Inc. et al

  1. December 03, 2020

    Dueling Attys Call For Xyrem MDL To Be Moved To CA Or NJ

    Lawyers for Blue Cross Blue Shield Association and Jazz Pharmaceuticals argued that lawsuits accusing Jazz of paying off rival drugmakers to delay their generic versions of Xyrem, its blockbuster narcolepsy drug, should be consolidated on either the West Coast or the East Coast in a Thursday hearing before the Judicial Panel on Multidistrict Litigation.

  2. July 14, 2020

    BCBS Says Generic Xyrem Delay Was Antitrust Scheme

    Blue Cross Blue Shield Association has accused Jazz Pharmaceuticals in California federal court of paying off generic-drug makers to delay their rival versions of the pharmaceutical giant's brand name narcolepsy drug Xyrem, arguing the alleged scheme caused buyers to overpay for the drug.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!